文献速递糖尿病肥胖与代谢综合征

人类GLP-1受体罕见杂合功能缺失变异与心脏代谢表型无关

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

在8642名丹麦2型糖尿病或糖耐量正常者中测序GLP1R,鉴定36个非同义变异,其中10个较野生型显著降低GLP-1诱导的cAMP信号;这些功能缺失变异与2型糖尿病无关联,携带者空腹血糖轻度升高。英国生物银行330566名白人外显子测序者中60个部分重叠的预测功能缺失变异亦无实质心脏代谢关联,仅对糖化血红蛋白有微小影响。

要点

  • 丹麦队列中10个GLP1R非同义变异较野生型显著降低GLP-1诱导的cAMP信号。
  • 功能缺失变异与2型糖尿病无关联,携带者空腹血糖轻度升高。
  • 英国生物银行预测功能缺失变异无实质心脏代谢关联,仅糖化血红蛋白有微小影响。

核心结论

  • 未发现纯合功能缺失或预测功能缺失变异,杂合携带者心脏代谢表型与非携带者相似,作者据此认为GLP-1R在人类生理中可能尤为重要,原因是 harmful 纯合GLP1R变异可能存在进化上的不耐受。

研究设计与样本

  • 在8642名丹麦2型糖尿病或糖耐量正常个体中测序GLP1R,并检测非同义变异结合GLP-1及在转染细胞中经cAMP生成和β-抑制蛋白招募传递信号的能力。
  • 在2930名2型糖尿病患者和5712名基于人群队列参与者中开展横断面研究,分析失去信号(LoS)变异负荷与心脏代谢表型的关系。
  • 在英国生物银行330566名无亲缘关系的白种外显子测序参与者中,研究心脏代谢表型与LoS变异负荷及60个部分重叠的预测功能缺失(pLoF)GLP1R变异负荷的关联。

主要发现

  • 在GLP1R中鉴定出36个非同义变异,其中10个较野生型在GLP-1诱导的cAMP信号上呈统计学显著降低。
  • LoS变异与2型糖尿病未见关联,但LoS变异携带者空腹血浆葡萄糖水平轻度升高。
  • 英国生物银行的pLoF变异也未显示实质心脏代谢关联,尽管对糖化血红蛋白A1c有微小影响。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Lost glucagon-like peptide 1 receptor (GLP-1R) function affects human physiology. OBJECTIVE: This work aimed to identify coding nonsynonymous GLP1R variants in Danish individuals to link their in vitro phenotypes and clinical phenotypic associations. METHODS: We sequenced GLP1R in 8642 Danish individuals with type 2 diabetes or normal glucose tolerance and examined the ability of nonsynonymous variants to bind GLP-1 and to signal in transfected cells via cyclic adenosine monophosphate (cAMP) formation and β-arrestin recruitment. We performed a cross-sectional study between the burden of loss-of-signaling (LoS) variants and cardiometabolic phenotypes in 2930 patients with type 2 diabetes and 5712 participants in a population-based cohort. Furthermore, we studied the association between cardiometabolic phenotypes and the burden of the LoS variants and 60 partly overlapping predicted loss-of-function (pLoF) GLP1R variants found in 330 566 unrelated White exome-sequenced participants in the UK Biobank cohort. RESULTS: We identified 36 nonsynonymous variants in GLP1R, of which 10 had a statistically significant loss in GLP-1-induced cAMP signaling compared to wild-type. However, no association was observed between the LoS variants and type 2 diabetes, although LoS variant carriers had a minor increased fasting plasma glucose level. Moreover, pLoF variants from the UK Biobank also did not reveal substantial cardiometabolic associations, despite a small effect on glycated hemoglobin A1c. CONCLUSION: Since no homozygous LoS nor pLoF variants were identified and heterozygous carriers had similar cardiometabolic phenotype as noncarriers, we conclude that GLP-1R may be of particular importance in human physiology, due to a potential evolutionary intolerance of harmful homozygous GLP1R variants.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Melchiorsen JU, Sørensen KV, Bork-Jensen J, et al. Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes. J Clin Endocrinol Metab. 2023. PMID: 37235780. doi:10.1210/clinem/dgad290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。